FreezeSpray TA
Cryosurgery, Inc. · Decision date Sep 5, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for FreezeSpray TA, a vapocoolant device, under 510(k) number K261684. The applicant is Cryosurgery, Inc. of Nashville, Tennessee. The application was received on 05/21/2026 and the decision date is 09/05/2026. The review panel is listed as Physical Medicine and the classification product code as MLY. SESE in this 510(k) context means the device was cleared as substantially equivalent to a predicate; it is not a PMA approval.
The public record identifies the submission as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. The specialty field is recorded as Unknown. The record does not describe the device's components, materials, intended indications, or the specific predicate device, so those details remain unknown from this source and would need the underlying FDA documents.
No clinical, efficacy, or patient-selection conclusions are drawn here; the record supports only the administrative clearance facts above.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Unknown
- Decision date
- Sep 5, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261684
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Cryosurgery, Inc.
- Product code
- MLY
- Decision code
- SESE
- Decision date
- Sep 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Vapocoolant Device.
- Applicant
- Cryosurgery, Inc.
- Product code
- MLY
- FDA device class
- U
FDA decision timeline
K261684 received
Application receipt date recorded by FDA.
K261684 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Cryosurgery, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Nashville, TN
Sources and methodology
- Original FDA record: K261684
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records